Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$103.41M
↑ 82% above average
Average (9y)
$56.85M
Historical baseline
Range
High:$273.63M
Low:$-129.64M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $103.41M | -43.5% |
| 2023 | $183.15M | -33.1% |
| 2022 | $273.63M | +4.6% |
| 2021 | $261.63M | +56.7% |
| 2020 | $166.99M | +4622.7% |
| 2019 | $3.54M | +104.4% |
| 2018 | $-79.50M | +23.4% |
| 2017 | $-103.77M | +20.0% |
| 2016 | $-129.64M | -16.8% |
| 2015 | $-110.98M | - |